Janux Therapeutics Inc (OQ:JANX)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for JANX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 17th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 5/24 Jun 3/24 Lichter Jay Indirect Ownership Common Stock S - Open market or private sale -691,525 $54.75
Jun 5/24 Jun 3/24 Lichter Jay Indirect Ownership Common Stock S - Open market or private sale -131,196 $54.75
Jun 5/24 Jun 3/24 Lichter Jay Indirect Ownership Common Stock S - Open market or private sale -677,279 $54.75
Jun 5/24 Jun 3/24 Reardon Tighe Indirect Ownership Common Stock S - Open market or private sale -691,525 $54.75
Jun 5/24 Jun 3/24 Reardon Tighe Indirect Ownership Common Stock S - Open market or private sale -131,196 $54.75
Jun 5/24 Jun 3/24 Avalon Ventures XI, L.P. Indirect Ownership Common Stock S - Open market or private sale -691,525 $54.75
Jun 5/24 Jun 3/24 Avalon Ventures XI, L.P. Indirect Ownership Common Stock S - Open market or private sale -131,196 $54.75
Jun 5/24 Jun 3/24 Avalon Ventures XI, L.P. Direct Ownership Common Stock S - Open market or private sale -677,279 $54.75
Mar 4/24 Feb 29/24 Avalon Ventures XI, L.P. Indirect Ownership Common Stock J - Other transaction -1,700  
Mar 4/24 Feb 29/24 Avalon Ventures XI, L.P. Indirect Ownership Common Stock J - Other transaction 1,700  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for JANX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 17th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 5/24 Jun 3/24 Lichter Jay Indirect Ownership Common Stock S - Open market or private sale -691,525 $54.75
Jun 5/24 Jun 3/24 Lichter Jay Indirect Ownership Common Stock S - Open market or private sale -131,196 $54.75
Jun 5/24 Jun 3/24 Lichter Jay Indirect Ownership Common Stock S - Open market or private sale -677,279 $54.75
Jun 5/24 Jun 3/24 Reardon Tighe Indirect Ownership Common Stock S - Open market or private sale -691,525 $54.75
Jun 5/24 Jun 3/24 Reardon Tighe Indirect Ownership Common Stock S - Open market or private sale -131,196 $54.75
Jun 5/24 Jun 3/24 Avalon Ventures XI, L.P. Indirect Ownership Common Stock S - Open market or private sale -691,525 $54.75
Jun 5/24 Jun 3/24 Avalon Ventures XI, L.P. Indirect Ownership Common Stock S - Open market or private sale -131,196 $54.75
Jun 5/24 Jun 3/24 Avalon Ventures XI, L.P. Direct Ownership Common Stock S - Open market or private sale -677,279 $54.75
Mar 4/24 Feb 29/24 Avalon Ventures XI, L.P. Indirect Ownership Common Stock J - Other transaction -1,700  
Mar 4/24 Feb 29/24 Avalon Ventures XI, L.P. Indirect Ownership Common Stock J - Other transaction 1,700  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $JANX

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Medpace Holdings (OQ:MEDP)
United Therapeutics (OQ:UTHR)
Moderna (OQ:MRNA)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.